Treatment

The utility of genetic testing in the management of hyperkinetic movement disorders 3:47
The utility of genetic testing in the management of hyperkinetic movement disorders
Marcelo Kauffman • 17 Sep 2022
Update on OCEAN and OASIS: Opicapone for pain & sleep disorders in PD 1:32
Update on OCEAN and OASIS: Opicapone for pain & sleep disorders in PD
K. Ray-Chaudhuri • 17 Sep 2022
Highlights from MDS: multidisciplinary teams, fluctuations & DBS 5:25
Highlights from MDS: multidisciplinary teams, fluctuations & DBS
Francisco Cardoso • 15 Sep 2022
What is the role of a neuropharmacist? 6:24
What is the role of a neuropharmacist?
Joela Mathews • 22 Jul 2022
Losmapimod as a potential treatment for facioscapulohumeral muscular dystrophy (FSHD) 8:29
Losmapimod as a potential treatment for facioscapulohumeral muscular dystrophy (FSHD)
Christopher Morabito • 11 Apr 2022
Should patients with a single unprovoked seizure be evaluated and treated as if they have epilepsy? 7:11
Should patients with a single unprovoked seizure be evaluated and treated as if they have epilepsy?
Anteneh Feyissa • 25 Mar 2022
At-home exercise and transcranial direct current stimulation (tDCS) for MS mobility 1:46
At-home exercise and transcranial direct current stimulation (tDCS) for MS mobility
Giuseppina Pilloni • 13 Apr 2022
Exercise intervention in patients with idiopathic generalized epilepsy 3:24
Exercise intervention in patients with idiopathic generalized epilepsy
Jane B. Allendorfer et al. • 3 Apr 2022
Research developments in exercise interventions for patients with epilepsy 1:20
Research developments in exercise interventions for patients with epilepsy
Jane B. Allendorfer • 3 Apr 2022
Developments in teleinterventions: tDCS with remote supervision for MS rehabilitation 9:21
Developments in teleinterventions: tDCS with remote supervision for MS rehabilitation
Giuseppina Pilloni et al. • 13 Apr 2022
Alternatives in HD treatment: RNA interference, small molecules, and combination approaches 5:14
Alternatives in HD treatment: RNA interference, small molecules, and combination approaches
Jee Bang • 4 Apr 2022
Using the visual pathway to treat MS 1:02
Using the visual pathway to treat MS
Christian Cordano • 4 Apr 2022
Molecular and cellular effects of exercise in neurological disorders 1:14
Molecular and cellular effects of exercise in neurological disorders
Jane B. Allendorfer • 3 Apr 2022
The unknowns of laser ablation therapy in epilepsy 1:29
The unknowns of laser ablation therapy in epilepsy
Brett Youngerman • 30 Mar 2022
Neuromodulation strategies as alternatives in epilepsy treatment 3:21
Neuromodulation strategies as alternatives in epilepsy treatment
Brett Youngerman • 30 Mar 2022
Important lines of research in progressive multiple sclerosis 2:54
Important lines of research in progressive multiple sclerosis
Lawrence Steinman • 11 Apr 2022
The content of VJNeurology is intended for healthcare professionals